Hasten Biopharmaceuticals’ Acquisition of 14 Product Portfolios from Celltrion Healthcare

Georgio Naffaa
Tagged:

Freshfields Bruckhaus Deringer (‘Freshfields’) advised Hasten Biopharmaceuticals on the acquisition.Hasten Biopharmaceuticals, a leading specialty pharmaceutical company based in China and a portfolio company of CBC Group,…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Georgio Naffaa

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here